LG Chem Unifies Three Osteoarthritis Collagen Injections Under "Rajean" Brand

LG Chem will unify the brand names of its three osteoarthritis collagen injection products under the name "Rajean."

On July 1, LG Chem announced that it will change the product name of Cartizol Extra, a collagen-based tissue supplement for osteoarthritis patients with knee joint (slight joint) conditions, to "Rajean Extra." With this change, the company will pursue integrated branding, bringing together the existing "Rajean Balance" and "Rajean Classic" under the unified brand.

LG Chem Osteoarthritis Collagen Injection Rajean 3 Types. Photo by LG Chem

"Rajean" is LG Chem's proprietary brand name, conveying the message of "making joints comfortable (An) with collagen." "Rajean Extra" is a two-dose formulation that can be administered up to two times within six months, while "Rajean Balance" is a three-dose formulation and "Rajean Classic" is a five-dose formulation.

Through this brand unification and renewal, LG Chem aims to establish a differentiated image from competitors in the rapidly expanding osteoarthritis medical device market, while consistently maintaining a customer-centric brand identity.

To ensure optimal quality management during the high-temperature summer season, LG Chem has established a cold-chain delivery system covering the entire distribution process, from receipt at the finished goods factory to storage, packaging, and shipment. Although Rajean products can be stored at room temperature below 30°C, LG Chem has chosen to implement even stricter refrigerated distribution in order to minimize quality deviations and stably supply products during the summer, when storage temperature fluctuations are significant. LG Chem stated that it will further enhance brand trust by emphasizing its competitive edge in Rajean's distribution and quality management.

In addition, LG Chem plans to continuously identify and implement effective measures to improve patient treatment satisfaction, such as minimizing injection pain.

Since developing Hiruanzu in 1997, Hiruanzu Plus in 2005, and Sinovian in 2014, all hyaluronic acid-based pharmaceuticals, LG Chem has led the domestic osteoarthritis market for over 30 years. Building on this foundation, the company is rapidly increasing the brand influence of Rajean, and based on last year's health insurance claim data and other sources, it estimates that the Rajean product line has surpassed a 40% market share in the relevant market.

Hwang Incheol, Head of LG Chem's Primary Care Business Division, said, "We plan to further enhance Rajean’s brand value by focusing on improving customer experience at the treatment site," adding, "We will continue to introduce products like Rajean and Sinovian that meet market demand, and expand marketing activities to drive innovation in customer experience."

This content was produced with the assistance of AI translation services.